Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Exacerbations in noncystic fibrosis bronchiectasis: Clinical features and investigations.

Kapur N, Masters IB, Chang AB.

Respir Med. 2009 Nov;103(11):1681-7. doi: 10.1016/j.rmed.2009.05.007. Epub 2009 Jun 6.

2.

Defining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis.

Kapur N, Masters IB, Morris PS, Galligan J, Ware R, Chang AB.

Pediatr Pulmonol. 2012 Jan;47(1):68-75. doi: 10.1002/ppul.21518. Epub 2011 Aug 9.

PMID:
21830316
3.

Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.

Chang AB, Grimwood K, Robertson CF, Wilson AC, van Asperen PP, O'Grady KA, Sloots TP, Torzillo PJ, Bailey EJ, McCallum GB, Masters IB, Byrnes CA, Chatfield MD, Buntain HM, Mackay IM, Morris PS.

Trials. 2012 Aug 31;13:156. doi: 10.1186/1745-6215-13-156.

4.

Exacerbations of chronic obstructive pulmonary disease.

Wedzicha JA, Donaldson GC.

Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Review.

5.

Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.

Chang AB, Grimwood K, Wilson AC, van Asperen PP, Byrnes CA, O'Grady KA, Sloots TP, Robertson CF, Torzillo PJ, McCallum GB, Masters IB, Buntain HM, Mackay IM, Ungerer J, Tuppin J, Morris PS.

Trials. 2013 Feb 20;14:53. doi: 10.1186/1745-6215-14-53.

6.

Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.

de Boer K, Vandemheen KL, Tullis E, Doucette S, Fergusson D, Freitag A, Paterson N, Jackson M, Lougheed MD, Kumar V, Aaron SD.

Thorax. 2011 Aug;66(8):680-5. doi: 10.1136/thx.2011.161117. Epub 2011 Jun 15.

PMID:
21680566
7.

Management of bronchiectasis and chronic suppurative lung disease in indigenous children and adults from rural and remote Australian communities.

Chang AB, Grimwood K, Maguire G, King PT, Morris PS, Torzillo PJ.

Med J Aust. 2008 Oct 6;189(7):386-93.

PMID:
18837683
8.

Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis.

Nazer D, Abdulhamid I, Thomas R, Pendleton S.

Pediatr Pulmonol. 2006 Aug;41(8):744-9.

9.

Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial.

Valery PC, Morris PS, Grimwood K, Torzillo PJ, Byrnes CA, Masters IB, Bauert PA, McCallum GB, Mobberly C, Chang AB.

BMC Pediatr. 2012 Aug 14;12:122.

10.

Characterization of lung function impairment in adults with bronchiectasis.

Guan WJ, Gao YH, Xu G, Lin ZY, Tang Y, Li HM, Lin ZM, Zheng JP, Chen RC, Zhong NS.

PLoS One. 2014 Nov 18;9(11):e113373. doi: 10.1371/journal.pone.0113373. eCollection 2014.

11.

Objective monitoring of cough in children with cystic fibrosis.

Hamutcu R, Francis J, Karakoc F, Bush A.

Pediatr Pulmonol. 2002 Nov;34(5):331-5.

PMID:
12357476
12.

[Inhaled antibiotics in the treatment of noncystic fibrosis bronchiectasis].

Martínez García MÁ, Soler Cataluña JJ, Serra PC.

Arch Bronconeumol. 2011 Jun;47 Suppl 6:19-23. doi: 10.1016/S0300-2896(11)70031-X. Review. Spanish.

13.

Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age.

Byrnes CA, Vidmar S, Cheney JL, Carlin JB, Armstrong DS, Cooper PJ, Grimwood K, Moodie M, Robertson CF, Rosenfeld M, Tiddens HA, Wainwright CE; ACFBAL Study Investigators.

Thorax. 2013 Jul;68(7):643-51. doi: 10.1136/thoraxjnl-2012-202342. Epub 2013 Jan 23.

14.

Cystic fibrosis clinical score: a new scoring system to evaluate acute pulmonary exacerbation.

Kanga J, Kuhn R, Craigmyle L, Haverstock D, Church D.

Clin Ther. 1999 Aug;21(8):1343-56.

PMID:
10485506
15.

Characterisation of the onset and presenting clinical features of adult bronchiectasis.

King PT, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW.

Respir Med. 2006 Dec;100(12):2183-9. Epub 2006 May 2.

16.

Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study.

Brill SE, Patel AR, Singh R, Mackay AJ, Brown JS, Hurst JR.

Respir Res. 2015 Feb 7;16:16. doi: 10.1186/s12931-015-0167-9.

17.

Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.

Regelmann WE, Schechter MS, Wagener JS, Morgan WJ, Pasta DJ, Elkin EP, Konstan MW; Investigators of the Epidemiologic Study of Cystic Fibrosis.

Pediatr Pulmonol. 2013 Jul;48(7):649-57. doi: 10.1002/ppul.22658. Epub 2012 Sep 4.

18.

Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children's hospital in New Zealand.

Edwards EA, Asher MI, Byrnes CA.

J Paediatr Child Health. 2003 Mar;39(2):111-7.

PMID:
12603799
19.

Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.

Makris D, Moschandreas J, Damianaki A, Ntaoukakis E, Siafakas NM, Milic Emili J, Tzanakis N.

Respir Med. 2007 Jun;101(6):1305-12. Epub 2006 Nov 16.

20.

Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.

Drobnic ME, Suñé P, Montoro JB, Ferrer A, Orriols R.

Ann Pharmacother. 2005 Jan;39(1):39-44. Epub 2004 Nov 23.

PMID:
15562142

Supplemental Content

Support Center